Reviva Pharmaceuticals Holdings logo
Reviva Pharmaceuticals Holdings RVPH
$ 1.34 0.0%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Reviva Pharmaceuticals Holdings Income Statement 2011-2024 | RVPH

Annual Income Statement Reviva Pharmaceuticals Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

82.8 M 76.3 M 42.7 M 22.5 M - - - - - - - - -

Shares

23.8 M 19.5 M 14.8 M 2.77 M - - - - - - - - -

Historical Prices

3.48 3.91 2.89 8.74 10.5 9.85 - - - - - - -

Net Income

-39.3 M -28.3 M -8.52 M -3.78 M -847 K - - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-39.5 M -28.2 M -10.1 M -2.43 M -377 K - - - - - - - -

Interest Expense

- - - 1.45 M 469 K - - - - - - - -

EBITDA

-39.5 M -28.2 M -10.1 M - -376 K - - - - - - - -

Operating Expenses

39.5 M 28.2 M 10.1 M 2.43 M - - - - - - - - -

General and Administrative Expenses

8.08 M 5.36 M 5.25 M 2.14 M 181 K - - - - - - - -

All numbers in USD currency

Quarterly Income Statement Reviva Pharmaceuticals Holdings

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

33.8 M 30.6 M 29.9 M 27.9 M 23.6 M 22.4 M 21.8 M 20.4 M 19.3 M 18.5 M 18.5 M 14.4 M 18.5 M 12.9 M 9.23 M 2.81 M 2.78 M 2.77 M 2.77 M 2.61 M 2.61 M 2.6 M 2.6 M 2.6 M 2.6 M 1.46 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-8.37 M -7.86 M -7.43 M - -11.3 M -11.7 M -6.85 M - -3.52 M -5.34 M -7.37 M - -2.28 M -1.61 M -949 K -348 K -659 K -851 K -749 K 137 K 750 K 274 K 338 K 263 K 263 K 17.7 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-8.46 M -8.13 M -7.92 M - -11.6 M -11.3 M -6.98 M - -3.56 M -5.52 M -7.45 M - -2.48 M -1.79 M -1.87 M -352 K -512 K -777 K -618 K -166 K -331 K -165 K -71.1 K -79.1 K -79.1 K -2.33 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-23.7 K -5.62 K 3.49 K - 5.19 K -19 7.66 K - - - - - - - - 3.8 K 146 K 99.1 K 130 K 324 K 1.07 M 750 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - -3.56 M -5.52 M -7.45 M - -2.48 M -1.79 M -1.87 M -352 K -512 K -777 K -618 K -166 K -331 K -165 K -71.1 K -79.1 K -79.1 K -2.33 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

8.46 M 8.13 M 7.92 M - 11.6 M 11.3 M 6.98 M - 3.56 M 5.52 M 7.45 M - 2.48 M 1.79 M 1.87 M 352 K 512 K 777 K 618 K 166 K 331 K 165 K 71.1 K 79.1 K 79.1 K 2.33 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

1.6 M 2.55 M 2.14 M - 1.99 M 3.08 M 1.5 M - 1.26 M 1.01 M 1.62 M - 1.05 M 1.42 M 1.48 M - 511 K 741 K 347 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency